Specific agonist TIRC7 antibodies have proven effective in animal models of immune-mediated diseases, e.g., kidney or heart transplant rejection, collagen-induced arthritis and acute graft-versus-host disease [20,21,22,23]. This evidence concerns the gene TCIRG1 and acute graft versus host disease.